Illinois Tool Works Inc. · ITW · FY2024 Q4 · Calendar Q1 2025
ITW: Record Quarter, Maintained Outlook, Execution Risks Remain
ITW's earnings support a margin-led resilience case, but the evidence for sustained growth is mixed: management reported record earnings and strong cash generation while revenue declined and maintained, rather than raised, its outlook. The next test is whether innovation and productivity initiatives can convert into broader volume growth without tariff, currency, or restructuring pressure eroding gains.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about ITW FY2024 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The quarter's analysis describes record earnings and margin performance despite a modest revenue decline. Compared with the prior quarter, guidance sentiment shifted from raised to maintained; management continued to emphasize innovation, productivity, product-line simplification, and selective M&A as the main levers.
Guidance delta
Management maintained its 2025 outlook: 0%–3% organic growth, EPS of $10.15–$10.55, and 100 basis points of margin improvement. This contrasts with the prior quarter's guidance raise.
Key takeaways
- Management emphasized margin expansion through enterprise initiatives, customer-backed innovation, and product-line simplification.
- China automotive and EV demand was highlighted as a source of strength, while broader order recovery remains uncertain.
- Capital allocation plans include disciplined M&A and a stated $1.5 billion 2025 share-repurchase program.
Management priorities
- Roll out the next phase of customer-backed innovation across divisions.
- Continue product innovation, product-line simplification, and productivity initiatives.
- Pursue selective acquisitions and execute the stated capital-allocation plan.
Follow ITW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Overweight | Downgrade | Oct 9, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Aug 11, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | May 4, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 4, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 1, 2026 |
| Goldman Sachs | Sell | Neutral | Downgrade | Dec 16, 2025 |
| B of A Securities | Neutral | Underperform | Upgrade | Nov 18, 2025 |
| UBS | Neutral | Neutral | Maintain | Jul 31, 2025 |
| Stifel | Hold | Hold | Maintain | Jul 31, 2025 |
| Jefferies | Hold | Hold | Maintain | Dec 6, 2024 |
| Morgan Stanley | Underweight | Underweight | Maintain | Aug 3, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 2, 2023 |
| Deutsche Bank | Sell | Sell | Maintain | Apr 12, 2023 |
| Vertical Research | Hold | Buy | Downgrade | Jan 3, 2023 |
| BMO Capital | Market Perform | Market Perform | Maintain | May 3, 2021 |
| CFRA | Sell | Sell | Maintain | Jan 31, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 29, 2019 |
| Northcoast Research | Sell | Neutral | Downgrade | Jun 26, 2019 |
| Argus Research | Buy | Buy | Maintain | Apr 26, 2019 |
| Bank of America | Underperform | Neutral | Downgrade | Feb 5, 2019 |
| Seaport Global | Neutral | Buy | Downgrade | Oct 25, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| RBC Capital | Perform | Sector Perform | Maintain | Nov 25, 2014 |
| ISI Group | Buy | Neutral | Upgrade | Aug 7, 2014 |
| Tigress Financial | Neutral | Neutral | Maintain | Mar 12, 2013 |
| Barrington Research | Outperform | Outperform | Maintain | Oct 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $272.28. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $277 | $264.71 | +1.7% | Oct 9, 2026 |
| Truist Financial | Analyst unavailable | $297 | $260.93 | +9.1% | Oct 5, 2026 |
| UBS | Steven Fisher | $300 | $296.5 | +10.2% | Jul 29, 2026 |
| Robert W. Baird | Analyst unavailable | $297 | $295.16 | +9.1% | Jul 29, 2026 |
| Wolfe Research | Nigel Coe | $286 | $266.56 | +5.0% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $301 | $268.97 | +10.5% | Jul 2, 2026 |
| Evercore ISI | Analyst unavailable | $272 | $254.72 | -0.1% | May 11, 2026 |
| Wells Fargo | Joseph O'Dea | $255 | $255.47 | -6.3% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $254 | $258.01 | -6.7% | Apr 30, 2026 |
| Barclays | Julian Mitchell | $275 | $293.57 | +1.0% | Feb 9, 2026 |
| Truist Financial | Analyst unavailable | $280 | $290.33 | +2.8% | Feb 4, 2026 |
| UBS | Analyst unavailable | $285 | $290.71 | +4.7% | Feb 4, 2026 |
| Robert W. Baird | Mircea Dobre | $278 | $278.91 | +2.1% | Feb 4, 2026 |
| Wells Fargo | Joseph O'Dea | $270 | $278.91 | -0.8% | Feb 4, 2026 |
| Goldman Sachs | Analyst unavailable | $253 | $278.91 | -7.1% | Feb 3, 2026 |
| Goldman Sachs | Analyst unavailable | $230 | $259.07 | -15.5% | Dec 16, 2025 |
| Truist Financial | Analyst unavailable | $275 | $245.75 | +1.0% | Oct 27, 2025 |
| Barclays | Analyst unavailable | $244 | $246.98 | -10.4% | Oct 27, 2025 |
| Robert W. Baird | Analyst unavailable | $265 | $247.12 | -2.7% | Oct 27, 2025 |
| Goldman Sachs | Analyst unavailable | $258 | $247.48 | -5.2% | Oct 27, 2025 |
| Wells Fargo | Joseph O'Dea | $245 | $245.75 | -10.0% | Oct 27, 2025 |
| Truist Financial | Analyst unavailable | $298 | $255.75 | +9.4% | Oct 8, 2025 |
| Evercore ISI | David Raso | $265 | $259.22 | -2.7% | Aug 19, 2025 |
| Truist Financial | Analyst unavailable | $283 | $253.67 | +3.9% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $252 | $255.89 | -7.4% | Mar 26, 2025 |
| Barclays | Julian Mitchell | $260 | $274.48 | -4.5% | Mar 10, 2025 |
| Wells Fargo | Joseph O'Dea | $250 | $248.59 | -8.2% | Jan 7, 2025 |
| CFRA | Jonathan Sakraida | $250 | $247.57 | -8.2% | Sep 10, 2024 |
| Wells Fargo | Joseph O'Dea | $236 | $249.34 | -13.3% | Jul 31, 2024 |
| Truist Financial | Jamie Cook | $281 | $249.34 | +3.2% | Jul 31, 2024 |
| Wells Fargo | Joseph O'Dea | $244 | $244.11 | -10.4% | May 1, 2024 |
| Wolfe Research | Nigel Coe | $250 | $262.94 | -8.2% | Apr 8, 2024 |
| Truist Financial | Jamie Cook | $303 | $262.67 | +11.3% | Mar 13, 2024 |
| Barclays | Analyst unavailable | $172 | $183.33 | -36.8% | Oct 3, 2022 |
| Morgan Stanley | Analyst unavailable | $191 | $206.61 | -29.9% | Aug 3, 2022 |
| Wells Fargo | Analyst unavailable | $187 | $204.9 | -31.3% | Aug 3, 2022 |
| Jefferies | Stephen Volkmann | $195 | $193.4 | -28.4% | Jul 26, 2022 |
| Barclays | Analyst unavailable | $167 | $185.64 | -38.7% | Jul 8, 2022 |
| Wells Fargo | Analyst unavailable | $185 | $182.99 | -32.1% | Jun 29, 2022 |
| Morgan Stanley | Analyst unavailable | $182 | $204.12 | -33.2% | May 31, 2022 |
| Barclays | Analyst unavailable | $180 | $199.78 | -33.9% | May 24, 2022 |
| UBS | Steven Fuller | $243 | $201.77 | -10.8% | May 21, 2022 |
| Morgan Stanley | Analyst unavailable | $187 | $209.05 | -31.3% | May 4, 2022 |
| Credit Suisse | Analyst unavailable | $261 | $208.85 | -4.1% | May 4, 2022 |
| Barclays | Analyst unavailable | $192 | $204.2 | -29.5% | May 4, 2022 |
| Deutsche Bank | Nicole DeBlase | $226 | $199.7 | -17.0% | May 2, 2022 |
| Stifel Nicolaus | Nathan Jones | $202 | $203.35 | -25.8% | Apr 23, 2022 |
| Barclays | Julian Mitchell | $200 | $206.43 | -26.5% | Apr 5, 2022 |
| Credit Suisse | Jamie Cook | $284 | $245.63 | +4.3% | Jan 13, 2022 |
| BMO Capital | Joel Tiss | $235 | $232.65 | -13.7% | Dec 2, 2021 |
| Jefferies | Stephen Volkmann | $260 | $224.16 | -4.5% | Oct 28, 2021 |
| UBS | Steven Fisher | $253 | $223.32 | -7.1% | Aug 5, 2021 |
| Wolfe Research | Nigel Coe | $243 | $223.8 | -10.8% | Jul 12, 2021 |
| Argus Research | John Eade | $260 | $230.68 | -4.5% | May 5, 2021 |
Track every rating change on ITW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationIllinois Tool Works Inc. is a global enterprise specializing in the production and distribution of a wide array of industrial goods and specialized equipment. The company operates through seven distinct divisions: Automotive OEM; Food Equipment; Test & Measurement and Electronics; Welding; Polymers & Fluids; Construction Products; and Specialty Products. The Automotive OEM division supplies plastic and metal components, various fastening solutions, and integrated assemblies for automobiles, light-duty trucks, and other industrial applications. Its Food Equipment segment delivers commercial kitchen appliances for washing, refrigeration, cooking, and food processing, alongside comprehensive kitchen exhaust, ventilation, and pollution control systems, and offers related maintenance and repair services.…
Historical context
All ITW earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the ITW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-22T00:04:22.296664+00:00
- Polygon adjusted daily market bars · 2026-10-18T14:10:41.569772+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T14:10:41.566802+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.